12.18.19
MedPharm has appointed Lynn Allen as vice president of business development. She will be based in San Francisco, CA and will be spearheading MedPharm’s top-line growth throughout North America. MedPharm continues to expand and grow its U.S. CDMO services for the pharmaceutical market supporting formulation development, cutting edge performance testing and flexible full-scale manufacture.
Lynn Allen joins the company with extensive experience in topical and transdermal contract development and manufacturing. During her career spanning nearly two decades in the CDMO space, Lynn has established her credibility for supporting clients and brings knowledge of the industry to drive forward MedPharm’s expanding service offering.
“Lynn is a fantastic addition to the MedPharm team,” said Eugene Ciolfi, MedPharm’s chief executive officer. “She brings a track record at attracting new customers and establishing strong relationships with key clients. Lynn can provide a local response to MedPharm’s West Coast clients who will increasingly benefit from our expanding facilities in North America.”
Lynn Allen joins the company with extensive experience in topical and transdermal contract development and manufacturing. During her career spanning nearly two decades in the CDMO space, Lynn has established her credibility for supporting clients and brings knowledge of the industry to drive forward MedPharm’s expanding service offering.
“Lynn is a fantastic addition to the MedPharm team,” said Eugene Ciolfi, MedPharm’s chief executive officer. “She brings a track record at attracting new customers and establishing strong relationships with key clients. Lynn can provide a local response to MedPharm’s West Coast clients who will increasingly benefit from our expanding facilities in North America.”